NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
Globenewswire·2025-08-08 20:03
Independent Study and Bioanalysis Suggests More Effective Nerve Repair and Faster Wound HealingTORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone outperformed a recognized commercial industry standard in areas that strongly support key healing tasks including nerve repair, wound repair, calming the immune system and rebuildin ...